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INTRODUCTION 
Because of the deficiency in availability of donor organs,
tissues harvested from suitable xenogeneic sources may pro-
vide reasonable alternatives for transplantation. There are
important immunologic concerns that require precise under-
standing of the relevant immune reactions prior to success-
ful xenotransplantation. Recently, a Gal knock out pig has
been developed which may help with the problems related
to hyperacute rejection of xenografts; the feasibility of clini-
cal use of such porcine xenografts is currently under investi-
gation. The cornea, an avascular organ, has an immune-privi-
leged environment and might be regarded as less immungene-
ic (1, 2). The naturally existing antibodies, presumed to be
the main obstacle for transplantation in other organs, might
not have an access directly to the graft in the cornea (3). Block-
age of xenonatural antibodies have had little effect on graft
survival in the cornea; therefore, the role of antibodies may
be limited in cornea xenotransplantation (4). By contrast, in
allografts, CD4+ T cells have been recognized as the main
cause of the corneal rejection; so the suppression of these cells
generally ensures long-term graft acceptance for the allo-
corneal graft (5). However, the exact mechanism involved in
rejection of a corneal xenograft remains still unclear. Moreover,
the immune system varies in every species, and each has spe-
cific antigen recognition. One report has suggested that T
cells are primarily involved in xeno-corneal graft rejection
in a mouse model; however, there is an another evidence of
non-T cell populations in other xenografts as well as in in-
flamed cornea (4, 6, 7). 
We have focused our investigation on the feasibility of
using porcine cornea for a xenograft; this is because pigs are
physiologically similar to human, have excellent breeding
characteristics, and have similar refractive properties to hu-
mans. In addition, porcine transplantation has been widely
investigated in other fields of medicine (8). Therefore, we
investigated the full features of cellular responses in ortho-
topic porcine-to-rat corneal transplantation by evaluating
the effect of immune suppressants on the survival of the graft
and by analyzing the changes of cytokine produced after trans-
plantation. 
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The Role of Cyclosporine and Mycophenolate in an Orthotopic
Porcine-to-Rat Corneal Xenotransplantation
We performed this study to investigate the feature of rejection in porcine-to-rat corneal
orthotopic transplantation and to evaluate the effect of cyclosporine and mycophe-
nolate on the xeno-rejection. Orthotopic corneal transplantation was done at 91
Sprague-Dawley rats, and they were divided into 10 groups based on the combina-
tion of immunosuppressants including dexamethasone, cyclosporine, and mycophe-
nolate mofetil. Graft survival was analyzed and grafted eyes were examined with
Hematoxylin & Eosin and CD4 or CD8 staining. Enzyme-linked immunosorbent
assays were done for interleukin-2 (IL-2), IL-4, IL-5, IL-10, and interferon (IFN)-γ in
cornea, lacrimal gland, and cervical lymph nodes. The longest median survival of
the immune suppressant group was 11.00± ±1.96 days, which showed no statisti-
cal differences compared with that of control (8.00± ±1.52 days). The neutrophils
were prominent in the early phase but soon gave way to the monocytes. The num-
ber of CD8+ cells was higher than that of CD4+ cells. IL-2 and IFN-γmarkedly
increased at 10 to13 days in cornea, lacrimal glands, and cervical lymph nodes,
which showed a decrease with immunosuppressants except in the cornea. In con-
clusion, cyclosporine and mycophenolate could not prevent the rejection in porcine
to rat orthotopic corneal xenograft associated with infiltraton of CD8+ and innate
immune cells. 
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MATERIALS AND METHODS
Orthotopic porcine-to-rat corneal transplantation
All procedures used in this study conformed to the prin-
ciples embodied in the ARVO Statement for the Use of Ani-
mals in Ophthalmic and Vision Research, and the protocol
was approved by the Research Ethics Committee at Seoul
National University Hospital. Ninety-one fresh porcine corneas
were obtained within six hours of death and were used for
this study. In addition, 91 Sprague-Dawley (10 week old) rats
were divided into 10 groups: 21 rats in control (Group 1),
and the others were divided according to the immune sup-
pressant regimen used after surgery: dexamethasone (DEXA)
2 mg/kg (Group 2, n=5), dexa 2 mg/kg with cyclosporine
A (CsA, Sandimum
�, Novatis, Basel, Switzerland) 10 mg/kg
(Group 3, n=5), dexa 1 mg/kg (Group 4, n=7), dexa 1 mg/
kg with CsA 5 mg/kg (Group 5, n=7), DEXA 1 mg/kg with
CsA 2.5 mg/kg (Group 6, n=6), dexa 1 mg/kg with CsA
1.25 mg/kg (Group 7, n=7), dexa 1 mg/kg with CsA 1.25
mg/kg and mycophenolate mofetil (MMF, CellCept
�, Roche,
Florence, SC, U.S.A.) 6 mg/kg (Group 8, n=8), dexa 1 mg/
kg with CsA 1.25 mg/kg and MMF 1.25 mg/kg (Group 9,
n=7), and the final Group 10 was treated daily with CSA
2.5 mg/kg peritoneally for a week prior to the surgery (n=
18). Then 0.1 cc of low molecular weight dextran sulfate
(MW 5000, 1 mg/mL) was injected intracamerally after
completion of surgery; they were then treated with DEXA
1 mg/kg, CsA 1.25 mg/kg, and MMF 1.25 mg/kg. All of
the immunosuppressant medications were applied after surgery
and injected intramuscularly once a day for two weeks regard-
less of the group. Animals were anesthetized by intramus-
cular injection of a combination of 10 mg/kg solution of
Zoletil (Virbac, Carros, France) and 2 mg/kg of Xylazine
(Bayer, Levorkusen, German). The cornea was fixed firmly
with an anterior chamber maintainer (Barron, Katena Prod-
uct, Denville, NJ, U.S.A.) and using an 8 mm-sized trephine
blade (Barron), the donor cornea was scored at 500 μ m depth,
and the anterior corneal lamella was removed carefully with
a crescent knife (Alcon, Fort Worth, TX, U.S.A.). The remain-
ing thin posterior lamella and endothelium were used to
compensate for the corneal discrepancy. They were trephined
from the inside with a 6 mm-sized blade (Mediprize, Seki,
Japan), and the recipient rat cornea was also trephined care-
fully with a 4 mm-sized blade (Mediprize), grasping the
globe firmly with the two fine tooth forceps until place at
the immediate entrance into the anterior chamber. The graft
was secured with 12 to 14 interrupted 10-0 nylon sutures
and tarsorrhaphy was performed finally at one-third of the
area from the lateral canthus to finally provide good coverage
of the corneal surface. Prednisolone acetate 1% (Pred forte
�,
Allergan, Irvine, CA, U.S.A.) and levofloxacin (Cravit
�, Aller-
gan, Irvine, CA, U.S.A.) were applied twice a day; in addi-
tion, apraclonidine 0.5% (Iopidine
�, Alcon), latanoprost 50
mg/mL (Xalatan, Pfizer, New York, NY, U.S.A.) and timo-
lol maleate 0.25% (Timoptix XE
�, Merck & Co., Inc. White-
house Station, NJ, U.S.A.) were instilled once a day after
surgery. The IOP was obtained with Tonopen (Tonolab,
Helsinki, Finland) until 13 days post-surgery to exclude the
possibility of other causes of corneal edema. Grafted eyes
were examined daily using an operating microscope (Carl
Zeiss, Oberkochen, Germany) and a portable slit lamp (Welch
& Allen, Jungingen, Germany) to evaluate edema and graft
rejection. Total graft rejection was defined as fully developed
graft edema or necrosis when the graft lost its transparency
and totally obscured the contour of the iris behind it. To eval-
uate the pattern of cell infiltration, one rat from the control
group were respectively sacrificed at 4, 7, 10, 13, and 16
days after transplantation, and the rest were sacrificed at the
time of clinically evident rejection. The median survivals of
the grafts in each group were calculated from the life table
method, and the statistical differences were verified with
log-rank test in 95% confidence interval (SPSS, Ver. 12.0).
The corneas were sent for histological evaluation or RNA
extraction. The infiltrating cells were stained with Hema-
toxylin & Eosin and were counted in five consecutive high
power fields (×400) under light microscopy. 
Immunohistochemical stain for T cells 
The corneas obtained from the control and Group 10 at
the postoperative 4, 7, 10, 13, and 16 days were fixed in 10%
neutral buffered formalin and incubated overnight at 4℃.
They were cut to 4 μ m thickness and dried at 60℃ for 1 hr
and deparaffinized with ethanol. Protenase K (20 μ g/mL,
Sigma, St. Louis, MO, U.S.A.), 3% H2O2 and 0.3% triton
X-100 were used for serially treatments and then 1% serum
was finally added. Then they were incubated at room tem-
perature with primary antibodies of CD4 (1:100 Chemicon,
Billerica, MA, U.S.A.), CD8 (1: 100, Chemicon) and PBS
(negative control). The anti-rabbit IgG (1:5,000, Southern-
biotech, Birmingham, AB, U.S.A.), anti-streptavidn (1:5,000,
Usbiological, Swampscott, MA, U.S.A.), and anti-mouse
IgG (1:5,000, Sigma) were used as secondary antibodies and
incubated for 30 min. The chromophore of Alexa 488 (1:500
Invitrogen, Carlsbad, CA, U.S.A.) and Hoechest 33342
(Sigma) were used for counter staining. At 400× magnifi-
cation, under the confocal microscopy confocal (LSM 510
Meta, Zeiss, Yena, Germany), the number of immunofluo-
rescent cells were counted five times in a single sample, and
the results were then averaged.
Evaluation of the changes of cytokines involved in 
rejection
The cornea, ipsilateral cervical lymph nodes, and lacrimal
glands were removed from the rats in the control and group
10 at 4, 7, 10, 13, and 16 days after transplantation; eachtissue was sliced with a scissor into small pieces and then
homogenized by a sonificator (Fisher, Pittsburgh, PA, U.S.A.).
The samples were again lysed in 350 μ L extraction buffer
(100 nM/L Tris HCL PH 8.0 and 10 mM/L lice) and were
then centrifuged at 2,500 rpm to remove cellular debris for 20
min. The supernatants were transferred to a new tube and
put into a deep freezer at -70℃. The detection and quan-
tification of protein from the cytokines produced were as fol-
lows. Briefly, the harvested proteins were diluted at 0.1 μ g
for each well in coating buffer (0.05 M carbonate bicarbonate
buffer) and incubated overnight at 4℃. Then they were wash-
ed in 0.15 M phosphate-buffered saline. The primary mono-
clonal mouse antibody of anti-rat IL-2 IL-4, IL-5, IL-10, and
IFN-γ(R&D systems, Minneapolis, MN, U.S.A.) were added
and incubated for 2 hr at 37℃. After washing three times
with PBS-buffered saline, secondary antibodies of 100 μ L
HRP-goat anti-mouse IgG conjugate (1:5,000, Invitrogen,
Carlsbad, CA) was added into each well. After 15 min later,
H2SO4 (1 M, 100 μ L) was also added finally, and the concen-
trations of each cytokine were measured using an enzyme-
liked immunosorbent assay (ELISA) kit (Molecular devices,
Sunnyvale, CA, U.S.A.) at 490 nm. Normal healthy tissues
were used to compare baseline activity.
In comparison to the xenograft without any systemic im-
munosuppression, the influence of intramuscularly injected
DEXA 1 mg/kg, CsA 1.25 mg/kg, and MMF 1.25 mg/kg
on the production of cytokines was investigated on the 10th
postoperative day, when most of the rejections were presumed
to occur. 
Statistical analysis 
Survival analysis using the life-table method was performed
to estimate the median time to graft failure in each group,
and the log-rank test were used to assess the statistical sig-
nificance of the differences in the median survival time bet-
ween the groups. Data were expressed as the median survival
time in the survival analysis and as mean±standard error
in the IOP, cell count, and ELISA analysis. 
RESULTS
Orthotopic porcine-to-rat corneal transplantation
In all rats, the mean IOP was well maintained until 10
days after surgery; then the IOP slowly went down and the
stromal necrosis followed (Fig. 1). The grafts looked clear,
and the anterior chamber was well reformed at 3 days after
surgery. In most of the rejections, the corneal edema that
obscured the iris structure was found at first; and then, severe
necrosis involving the corneal stroma developed soon (Fig.
2). The median survival was 9.26 days for the control group
(Group 1) in the orthotopic porcine-to-rat corneal xenograft,
while it was 7.00 days (p=0.21) for Group 2 with dexametha-
sone 2 mg/kg, 7.25 days (p=0.11) for Group 3 with dexam-
ethazone 2 mg/kg and cyclosporin A 10 mg/kg, 9.50 days
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Fig. 1. Mean IOP of orthotopic rat corneal xenotransplantation.
The measured IOP was well controlled until 10 day after surgery
with some decline due to the tissue destruction as the rejection
proceeded.
Fig. 2. Clinical features of porcine-to-rat orthotopic corneal transplantation. (A) Immediate after surgery, the graft looked clear. (B) At the
time of rejection, the shadow of iris was lost and most rats showed severe stromal necrosis (13 days after surgery).
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Fig. 3. (A) The survival curve of grafts without any systemic immunosuppression and with immunosuppression (life table method), (B) sur-
vival analysis of grafts based on the immunosuppressive regimen (life table method). The median survival was not significantly different
among all the groups included in this study (Log-rank test). 
Group 1, Control (n=21); Group 2, Dexamethasone 2 mg/kg (n=5); Group 3, Dexamethazone 2 mg/kg+cyclosporin A 10 mg/kg (n=5);
Group 4, Dexamethasone 1 mg/kg (n=7); Group 5, Dexamethazone 1 mg/kg+cyclosporin A 5 mg/kg (n=7); Group 6, Dexamethazone 1
mg/kg+cyclosporin A 2.5 mg/kg (n=6); Group 7, Dexamethazone 1 mg/kg+cyclosporin A 1.25 mg/kg (n=7); Group 8, Dexamethazone 1
mg/kg+cyclosporin A 1.25 mg/kg+Mycophenolate mofetil 6 mg/kg (n=8); Group 9, Dexamethazone 1 mg/kg+cyclosporin A 1.25 mg/kg+
Mycophenolate mofetil 1.25 mg/kg (n=7); Group 10, Dexamethazone 1 mg/kg+cyclosporin A 1.25 mg/kg+Mycophenolate mofetil 1.25
mg/kg and pretreatment with dextran 1 mg/mL, intracameral injection and cyclosporin A 2.5 mg/kg intraperitoneal injection for a week
injection (n=18)
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Fig. 4. The inflammatory cells infiltration after porcine-to-rat xenotransplantation. At 4 days after graft, there were relatively few cells and
polymorphonuclear cells (PMNs) were dominant (A, red arrows indicate PMNs; ×400). Many infiltrating cells were found, deep in the
stroma at 7 days (B, red arrows indicate PMNs, white arrows indicate monocytes; ×400). However, most infiltrating cells were replaced
by monocytes or lymphocytes at 10 days (C, ×400) and 13 days (D, ×200).  
A B
C D(p=0.10) for Group 4 with dexamethasone 1 mg/kg, 10.25
days (p=0.91) for Group 5 with dexamethazone 1 mg/kg and
cyclosporin A 5 mg/kg, 9.07 days (p=0.71) for Group 6 with
dexamethazone 1 mg/kg and cyclosporin A 2.5 mg/kg, 8.77
days (p=0.64) for Group 7 with dexamethazone 1 mg/kg and
cyclosporin A 1.25 mg/kg, 11.35 days (p=0.75) for Group
8 with dexamethazone 1 mg/kg, cyclosporin A 1.25 mg/kg
and mycophenolate mofetil 6 mg/kg, 8.50 days (p=0.16) for
Group 9 with dexamethazone 1 mg/kg, cyclosporin A 1.25
mg/kg, and mycophenolate mofetil 1.25 mg/kg, and 9.87
days (p=0.74) for Group 10 with dexamethazone 1 mg/kg,
cyclosporin A 1.25 mg/kg, mycophenolate mofetil 1.25
mg/kg, and pretreatment with dextran 1 mg/mL, intracam-
eral injection and cyclosporin A 2.5 mg/kg intraperitoneal
injection for a week injection; these survivals were not sig-
nificantly different from the control (Fig. 3). 
The histological findings of the grafts
In the early phase of post-surgery on day 4, the dominant
infiltrating cells were polymorphonuclear cells (PMNs); how-
ever, from the 7th day, the cells began to infiltrate deep into
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Fig. 5. The feature of inflammatory cells infiltrated after porcine-
to-rat xenotransplantation. PMNs dominate until 10 days, and then
monocytes are increasing after 7 days. The number of lympho-
cytes was not very high until the last examination. 
*The percent denoted the expression of the individual cells against
the whole inflammatory cells.
N, polymorphonuclear neutrophils; P, plasma cell; L, lymphocyte;
M, monocyte; Ma, macrophage.
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Fig. 6. The immunohistochemical staining of the grafts in the control (A, B) and immunosuppressed rats (C, D) at 10 days showed few
reactive cells indicating CD4+ cells (A and C, ×400, white arrows indicate stained cells), and a relatively higher number of positively stained
CD8 + cells (B and D, ×400, white arrows indicate stained cells).
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the stroma and the mononuclear cells increased in number
(Fig. 4, 5). At 13 days after surgery, some activated fibrob-
lasts were seen in the stroma, but most of the layered archi-
tecture was almost completely destroyed. CD4+ lympho-
cytes and CD8+ lymphocytes were observed at 7 days, but
they were few in number (Fig. 6). The immunohistochemi-
cal staining revealed that the number of CD4+ stained cells
was always smaller than that of the CD8+ stained cells till
the 16 days. Mean percentages of CD8+ expressed cells were
higher (15%) than those of CD4+ stained cells (7%) through-
out the study period (Fig. 7). 
The cytokine changes in xenograft rejection
The expression of IL-2 and IFN-γdemonstrated a steady
increase in all tissues while there was a rapid remarkable in-
crease in the cornea at about 10 to 13 days after transplanta-
tion. The increase of IL-4 was found at 10 days in the lacrimal
glands and cervical lymph nodes (Fig. 8). After suppression
of cellular reactivity with the application of Dexa 1 mg/kg,
CsA 1.25 mg/kg and MMF 1.5 mg/kg, the production of
IL-2, IL-4 and IFN-γwas markedly reduced in the lacrimal
glands and lymph nodes. However, there was no reduction
of IL-2, IL-4, IL-10, and IFN-γin the cornea, even with sys-
temic immune suppression (Fig. 9). 
DISCUSSION
We found cyclosporine and mycophenolate combined with
dexamethasone did not prolong the median survival in ortho-
topic porcine-to-rat corneal xenotransplantation. Histology
showed that the main infiltrative cells were monocytes and
CD8+ lymphocytes during the rejection, and cytokine assay
revealed the time gap between the rising time of IL-2 and
IFN-γ(10-13 days) and the median rejection time (8 days),
suggesting that CD4+ cell-mediated delayed type cellular
rejection seems not to be mainly involved in rejection of this
porcine-rat xeno-model.
In spite of an urgent need for alternatives to human organ
donation for transplantation, the outcome of xenografts remains
unclear. We investigated the immunological feasibility of
using a porcine cornea as a xenograft for human transplanta-
tion. There is some data on porcine islet cells as well as kid-
ney and heart cells transplanted into primate recipients (8-
10). However, these outcomes cannot be directly applied to
draw conclusions regarding porcine corneal transplantation
because the cornea differs from other organs; it has no blood
vessels, is regarded to be immune privileged, and is exposed
directly to the environment with continuous exposure to
pathogens. We started our investigations with a porcine-to-
rat animal model as the first step for the evaluation of mech-
anisms of rejection; although primate experiments may have
been preferred, which was not an option for us at this time.
Among the animals that are widely used in the ophthalmic
research, rats are easy to acquire the antibodies for an in vitro
assay, compared to rabbits, and have larger corneas than mice,
thus easier to operate on and observe the outcome after surgery. 
The predominant role of humoral immunity has been exten-
sively studied, and the recent advances with transgenic or
cloned pigs, together with the scanty distribution of the
xenonatural antibody a-gal (gal alpha 1-3gal beta 1-4Glc-
NAc-R) epitope, as well as the immune privileged environ-
ment of the cornea, have made it possible to overcome hyper-
acute rejection regardless of the presence of immunoglobu-
lin or B lymphocytes in the graft (1, 2, 11). Actually, the
porcine-to-rat model is disconcordant in terms of pedigree.
While considering both rats and pigs that have a-gals, the
porcine-to-rat model is a concordant model in terms of a-gal
aspect. Therefore, we did not expect a hyperacute rejection
associated with a-gal in these models. However, there remains
the possibility of acute or delayed graft rejection in associa-
P
e
r
c
e
n
t
 
(
%
)
*
30
25
20
15
10
5
0
-5
Fig. 7. The ratio of specific T-cells against the whole infiltrating cells per high power field in the control (A) and immunosuppressed cornea
(B) at 10 days. The surface reactivity for the CD4, CD8 cells were relatively low regardless of the time spent. There was no significant dif-
ferences between the control and immunosuppressed groups. 
*Percent (%) denotes the expression of positively stained cells for anti-CD4, CD8 antibody against the whole cells.
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tion with innate immune cells or T lymphocytes associated
with adaptive responses even if immunoglobulins do not
directly influence the graft. There is some evidence that even
the nonvascularized tissue, such as pancreatic islet cells or
neuronal tissue, which are not susceptible to anti-a-gal anti-
bodies directly, can be destroyed by different immune path-
ways (12, 13). Generally, the rejection associated with a corneal
allograft is mediated primarily by CD4+ T cells; one report
has suggested a critical role for CD4+ T cells in xeno-corneal
rejection in a guinea pig-to-mouse xeno-model (4, 14). This
finding led us to investigate the role of CD4+ T cells in a
porcine-to-rat xeno-corneal transplantation model and to
evaluate the positive effect of immunosuppressants on the
survival. 
Contrary to our expectation, cyclosporine and mycopheno-
late mofetil could not prolong the median survival, although
they are potent immunosuppressive agents that can mainly
suppress the activity of T and B cells (15). The late increase
of IL-2 and IFN-γsuggested CD4+ cell-mediated cellular
responses developed after 10-13 days, and it seemed to dis-
match with the median rejection periods of the grafts. Effec-
tor CD8+cells also amounted to less than 15% throughout
the rejection, but the number was higher than that of CD4+
cells. The time of emerging innate inflammatory cells such
as neutrophils and monocytes before CD4+ cells render them
activate corresponds with the time of rejection. Taken togeth-
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Fig. 8. Cytokine production in normal xenografts. The expression
of IL-2 and IFN-γincreased steadily after surgery in all tissues,
but the IL-4 showed a peak at 10 days in lacrimal glands and
lymph nodes.
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er, the rejection mechanism of the xeno-corneal transplanta-
tion in rats was more associated with effector CD8+ T cells
and innate cellular reaction rather than CD4+ cell-orches-
trated delayed type cellular rejection. These findings were
consistent with previous studies that suggested the impor-
tance of non-CD4+ T cell mediated rejection in xenotrans-
planatation (16-18). For xenotransplantation conditions, the
normal host immune cells might fail to respond adequately
to a xenogeneic antigen; certain accessory adhesion molecules
and cytokines are species-specific (19). Therefore, in contrast
to the critical role of the CD4+ T cell in delayed rejection of
allografts, non-T cell involvement might play a more impor-
tant role in cellular rejection of a xenograft (20-22). Also, in
a xenograft model of an athymic rat as recipient, the involve-
ment of macrophages and NK-cell infiltrate have also been
observed (7). The possible failure of the recipient NK cell’s
inhibitory receptor to recognize the species-specific donor
MHC I might increase the susceptibility for non-CD4+ T
cell-mediated graft rejection as well. However, whether xeno-
graft rejection is primarily dependent on CD4+ T cells and
NK depletion continues to be debated (16, 17). We believe
that each type of immune cell may have a partial contribu-
tion to xenograft rejection, and their expression is likely to
be time-dependent. This concept may be applied to the cur-
rent model reported here in that the cells that represented
innate immunity may have destroyed most of the graft at
first before the activation of the adaptive immune system
represented by T cells in the porcine-to-rat xeno-corneal trans-
plantation. We are currently investigating the role of NK
cells and macrophages in xeno-corneal transplantation. 
Meanwhile, the low molecular weight dextran sulfate (MW
5000) is known to protect target cells from complement acti-
vation and NK cell-mediated injury (23). However, our study
showed the addition of 1 mg/mL of low molecular weight
Fig. 9. Cytokine profile in the xenografts after immune suppres-
sion. After systemic suppression of cellular reactivity, the cytokines
produced in lacrimal gland and lymph node showed generalized
reduction. However, in the cornea the cytokines were not sup-
pressed efficiently. 
Control, normal cornea without transplantation; Non-suppression,
transplanted cornea without systemic immunosuppression; Sup-
pression, transplanted cornea with systemic immunosuppres-
sion containing dexamethazone 1 mg/kg+cyclosporin A 1.25
mg/kg+mycophenolate mofetil 1.25 mg/kg. and pretreatment
with dextran 1 mg/mL, intracameral injection and cyclosporin A
2.5 mg/kg intraperitoneal injection for a week injection.
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dextran sulfate in Group 10 failed to prolong graft survival. 
Considering that IFN-γand IL-2 were found to marked-
ly increase in the cornea, lacrimal glands and cervical lymph
nodes after 10-13 days, Th1 cells appeared to be actively in-
volved in the cellular reaction at that time. However, we could
not confirm an association of Th2; this was because IL-4, IL-
5, and IL-10 increased very little or showed only equivocal
changes compared with the control. The inefficient reduc-
tion of IL-2, IL-4, IL-10, and IFN-γin the cornea, even with
systemic immunosuppressants, suggested that the systemic
immune suppressants could not reach the cornea in time
because of its poor vascularity. More studies would be required
about the reason why IFN-γwas rather increased in the cornea
with immunosuppression, compared to that without immuno-
suppression.
Although our result was partially limited because T cells
might not be fully blocked with our regimens, other findings
including these support the importance of innate immune
cells having a primary role in cellular rejection of the porcine
graft before CD4+ T cell-mediated rejection occurred. 
In conclusion, acute innate cellular reaction and effector
CD8+ T cells appears to play a key role in the porcine-to-rat
orthotopic corneal xenograft rejection before the involvement
of delayed cellular responses demonstrated by CD4+ T cells.
These findings provide the basis for better understanding of
the immunology of xeno-corneal transplantation.
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